Literature DB >> 21593153

Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers.

Philip A Mudd1, Adam J Ericsen, Andrew A Price, Nancy A Wilson, Keith A Reimann, David I Watkins.   

Abstract

A small percentage of human immunodeficiency virus (HIV)- and simian immunodeficiency virus (SIV)-infected individuals spontaneously control virus replication. The majority of these elite controllers mount high-frequency virus-specific CD4(+) T cell responses. To evaluate the role these responses might play in viral control, we depleted two elite controller macaques of CD4(+) cells. SIV-specific CD4(+) T cell responses did not return to baseline levels until 8 weeks postdepletion. Viral loads remained stable throughout the experiment, suggesting that SIV-specific CD4(+) T cell responses may not play a direct role in controlling chronic viral replication in these elite controllers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593153      PMCID: PMC3126606          DOI: 10.1128/JVI.00738-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication.

Authors:  Levi J Yant; Thomas C Friedrich; Randall C Johnson; Gemma E May; Nicholas J Maness; Alissa M Enz; Jeffrey D Lifson; David H O'Connor; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.

Authors:  John T Loffredo; Benjamin J Burwitz; Eva G Rakasz; Sean P Spencer; Jason J Stephany; Juan Pablo Giraldo Vela; Sarah R Martin; Jason Reed; Shari M Piaskowski; Jessica Furlott; Kim L Weisgrau; Denise S Rodrigues; Taeko Soma; Gnankang Napoé; Thomas C Friedrich; Nancy A Wilson; Esper G Kallas; David I Watkins
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

3.  The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.

Authors:  Juan P Giraldo-Vela; Richard Rudersdorf; Chungwon Chung; Ying Qi; Lyle T Wallace; Benjamin Bimber; Gretta J Borchardt; Debra L Fisk; Chrystal E Glidden; John T Loffredo; Shari M Piaskowski; Jessica R Furlott; Juan P Morales-Martinez; Nancy A Wilson; William M Rehrauer; Jeffrey D Lifson; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

Review 4.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

5.  Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys.

Authors:  Nichole R Klatt; Francois Villinger; Pavel Bostik; Shari N Gordon; Lara Pereira; Jessica C Engram; Ann Mayne; Richard M Dunham; Benton Lawson; Sarah J Ratcliffe; Donald L Sodora; James Else; Keith Reimann; Silvija I Staprans; Ashley T Haase; Jacob D Estes; Guido Silvestri; Aftab A Ansari
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

6.  Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection.

Authors:  Jonah B Sacha; Juan P Giraldo-Vela; Matthew B Buechler; Mauricio A Martins; Nicholas J Maness; Chungwon Chung; Lyle T Wallace; Enrique J León; Thomas C Friedrich; Nancy A Wilson; Atsunobu Hiraoka; David I Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

7.  Mamu-B*08-positive macaques control simian immunodeficiency virus replication.

Authors:  John T Loffredo; Jess Maxwell; Ying Qi; Chrystal E Glidden; Gretta J Borchardt; Taeko Soma; Alex T Bean; Dominic R Beal; Nancy A Wilson; William M Rehrauer; Jeffrey D Lifson; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

8.  Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques.

Authors:  Laura E Valentine; John T Loffredo; Alex T Bean; Enrique J León; Caitlin E MacNair; Dominic R Beal; Shari M Piaskowski; Yann C Klimentidis; Simon M Lank; Roger W Wiseman; Jason T Weinfurter; Gemma E May; Eva G Rakasz; Nancy A Wilson; Thomas C Friedrich; David H O'Connor; David B Allison; David I Watkins
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

9.  Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.

Authors:  John T Loffredo; Alex T Bean; Dominic R Beal; Enrique J León; Gemma E May; Shari M Piaskowski; Jessica R Furlott; Jason Reed; Solomon K Musani; Eva G Rakasz; Thomas C Friedrich; Nancy A Wilson; David B Allison; David I Watkins
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

10.  CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.

Authors:  John T Loffredo; Thomas C Friedrich; Enrique J León; Jason J Stephany; Denise S Rodrigues; Sean P Spencer; Alex T Bean; Dominic R Beal; Benjamin J Burwitz; Richard A Rudersdorf; Lyle T Wallace; Shari M Piaskowski; Gemma E May; John Sidney; Emma Gostick; Nancy A Wilson; David A Price; Esper G Kallas; Helen Piontkivska; Austin L Hughes; Alessandro Sette; David I Watkins
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

View more
  11 in total

1.  Reactivation of Simian Varicella Virus in Rhesus Macaques after CD4 T Cell Depletion.

Authors:  Vicki Traina-Dorge; Brent E Palmer; Colin Coleman; Meredith Hunter; Amy Frieman; Anah Gilmore; Karen Altrock; Lara Doyle-Meyers; Maria A Nagel; Ravi Mahalingam
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

2.  Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.

Authors:  Timothée Bruel; Chiraz Hamimi; Nathalie Dereuddre-Bosquet; Antonio Cosma; So Youn Shin; Aurélien Corneau; Pierre Versmisse; Ingrid Karlsson; Benoit Malleret; Brice Targat; Françoise Barré-Sinoussi; Roger Le Grand; Gianfranco Pancino; Asier Sáez-Cirión; Bruno Vaslin
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

3.  Socialization strategies and disease transmission in captive colonies of nonhuman primates.

Authors:  Steven J Schapiro; Bruce J Bernacky
Journal:  Am J Primatol       Date:  2011-09-08       Impact factor: 2.371

4.  A novel monoclonal antibody to CD40 prolongs islet allograft survival.

Authors:  M Lowe; I R Badell; P Thompson; B Martin; F Leopardi; E Strobert; A A Price; H S Abdulkerim; R Wang; N N Iwakoshi; A B Adams; A D Kirk; C P Larsen; K A Reimann
Journal:  Am J Transplant       Date:  2012-05-08       Impact factor: 8.086

5.  NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model.

Authors:  Diego A Vargas-Inchaustegui; Peng Xiao; Iskra Tuero; L Jean Patterson; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2012-07-13       Impact factor: 5.422

6.  Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques.

Authors:  Deborah Heydenburg Fuller; Premeela Rajakumar; Jenny W Che; Amithi Narendran; Julia Nyaundi; Heather Michael; Eric J Yager; Cristy Stagnar; Brendon Wahlberg; Rachel Taber; Joel R Haynes; Fiona C Cook; Peter Ertl; John Tite; Angela M Amedee; Michael Murphey-Corb
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

7.  B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers.

Authors:  Yoshinori Fukazawa; Richard Lum; Afam A Okoye; Haesun Park; Kenta Matsuda; Jin Young Bae; Shoko I Hagen; Rebecca Shoemaker; Claire Deleage; Carissa Lucero; David Morcock; Tonya Swanson; Alfred W Legasse; Michael K Axthelm; Joseph Hesselgesser; Romas Geleziunas; Vanessa M Hirsch; Paul T Edlefsen; Michael Piatak; Jacob D Estes; Jeffrey D Lifson; Louis J Picker
Journal:  Nat Med       Date:  2015-01-19       Impact factor: 53.440

Review 8.  Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.

Authors:  Elena Gonzalo-Gil; Uchenna Ikediobi; Richard E Sutton
Journal:  Yale J Biol Med       Date:  2017-06-23

Review 9.  CD8+ T cells in HIV control, cure and prevention.

Authors:  David R Collins; Gaurav D Gaiha; Bruce D Walker
Journal:  Nat Rev Immunol       Date:  2020-02-12       Impact factor: 53.106

10.  CD8+ and CD4+ cytotoxic T cell escape mutations precede breakthrough SIVmac239 viremia in an elite controller.

Authors:  Benjamin J Burwitz; Juan Pablo Giraldo-Vela; Jason Reed; Laura P Newman; Alexander T Bean; Francesca A Nimityongskul; Philip A Castrovinci; Nicholas J Maness; Enrique J Leon; Richard Rudersdorf; Jonah B Sacha
Journal:  Retrovirology       Date:  2012-11-06       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.